ACTRN12607000043437终止4 期
Weekly Carboplatin and Taxol with concurrent radiotherapy for locally advanced non small cell lung cancer:Predictive factors for completion of treatment.
South Eastern Illawarra Area Health service0 个研究点目标入组 45 人开始时间: 2007年1月12日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 终止
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 17 Years 至 ot stated（—）
- 性别
- All
入选标准
- •Stage IIIA/B histologically proven NSCLC. ECOG Performance Status 0 or1. Weight loss < 10% compared to original (pre-diagnosis) weight. FeV1 (Forced Expiratory volume 1 second) > 1.0L. Adequate hematological and biochemical reserve.
排除标准
- •Glomerular Filtration Rate (GFR) < 50ml/min (Cockroft-Gault formula). Prior chemotherapy or irradiation. Prior diagnosis of invasive cancer within the last 2 years. Symptomatic sensory or motor neuropathy. Contraindications to steroids. Pregnant or breastfeeding mothers. Intercurrent medical illnesses precluding combined modality therapy (except with clinician's authorisation).
研究者
相似试验
招募中
不适用
Weekly nab-Paclitaxel+Carboplatin with Radiotherapy as First Line Therapy in Patients with Advanced Non-Small-Cell Lung Canceron-Small-Cell Lung CancerJPRN-UMIN000031017niversity of Fukui Faculty of Medical Sciences25
已完成
3 期
Carboplatin and Paclitaxel (Taxol) versus Carboplatin and Paclitaxel (Taxol) followed by Carboplatin for frontline chemotherapy in advanced ovarian carcinoma. A Hellenic Cooperative Oncology Group StudyACTRN12610000309088Hellenic Cooperative Oncology Group412
进行中（未招募）
不适用
Weekly therapy with Carboplatin and Docetaxel in patients with head-neck cancer with important comorbidity (ancer patients with chronic cardiac or circulatory disorders, people who have had cardiovascular accidents in the past, people with renal failure, etc.).Patients with head and neck cancer having high comorbidityMedDRA version: 14.1Level: SOCClassification code 10029104Term: Neoplasms benign, malignant and unspecified (incl cysts and polyps)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-003509-65-ITISTITUTO ONCOLOGICO VENETO
已完成
2 期
Phase II study of Carboplatin, weekly Paclitaxel and Bevacizumab in elderly patients with advanced non-squamous non-small-cell lung cancer (NEJ 016)non-small cell lung cancerJPRN-UMIN000006622orth East Japan Study Group36
招募中
3 期
A clinical trial to study the effect of weekly paclitaxel in advanced epithelial ovarian cancerCTRI/2010/091/000037Department of Biotechnology Ministry of Science and Technology270